Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

Blood. 2011 Mar 31;117(13):3696-7. doi: 10.1182/blood-2010-11-320937.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials as Topic
  • Cytogenetic Analysis
  • Diagnosis, Differential
  • Genetic Testing
  • Humans
  • Isocitrate Dehydrogenase / genetics*
  • Leukemia, Myeloid, Acute / diagnosis*
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / pathology
  • Mutation* / physiology
  • Prognosis
  • Survival Analysis
  • Treatment Outcome

Substances

  • IDH2 protein, human
  • Isocitrate Dehydrogenase